e-learning
resources
Virtual 2021
07.09.2021
COVID - 19 around the globe
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Prevalence and impact of comorbidities in Tunisian moderate to severe COVID-19 patients
L. Kaabi (tunis, Tunisia), S. Louhaichi (tunis, Tunisia), I. Khalfallah (tunis, Tunisia), R. Jebali (tunis, Tunisia), S. Marzouki (tunis, Tunisia), M. Kharrat (tunis, Tunisia), J. Ammar (tunis, Tunisia), A. Hamzaoui (tunis, Tunisia)
Source:
Virtual Congress 2021 – COVID - 19 around the globe
Session:
COVID - 19 around the globe
Session type:
E-poster
Number:
3807
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
L. Kaabi (tunis, Tunisia), S. Louhaichi (tunis, Tunisia), I. Khalfallah (tunis, Tunisia), R. Jebali (tunis, Tunisia), S. Marzouki (tunis, Tunisia), M. Kharrat (tunis, Tunisia), J. Ammar (tunis, Tunisia), A. Hamzaoui (tunis, Tunisia). Prevalence and impact of comorbidities in Tunisian moderate to severe COVID-19 patients. 3807
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Related content which might interest you:
Prevalence and impact of chronic respiratory disease in moderate to severe COVID-19 outcomes
Source: Virtual Congress 2021 – Clinical features and challenges of COVID-19
Year: 2021
Prevalence of comorbidities in patients with COPD in south-Spain
Source: Annual Congress 2011 - Respiratory epidemiology: comorbidity
Year: 2011
Prevalence of comorbidity in patients with COPD and its effect on mortality
Source: Annual Congress 2003 - Staging and outcome in COPD
Year: 2003
Prevalence and determinants of anaemia in hospitalized elderly COPD patients
Source: Annual Congress 2008 - COPD in the elderly - quality of life and scores in COPD
Year: 2008
Prevalence and risk factors of co-morbidities in subjects with mild and moderate COPD detected by screening
Source: Annual Congress 2013 –The best abstracts in extra-pulmonary features and pulmonary rehabilitation
Year: 2013
High prevalence of COPD symptoms in the Tunisian population contrasting with low awareness of the disease
Source: Annual Congress 2012 - Prevalences and characterstics of obstructive airway disease
Year: 2012
Prevalence and risk factors of depression in patients with COPD
Source: Annual Congress 2009 - Comorbidities and case management in primary respiratory care
Year: 2009
Identification of treatable traits in a severe asthma registry: prevalence and exacerbation predictors
Source: International Congress 2018 – Clinical determinants of asthma and biomarkers
Year: 2018
High prevalence of undiagnosed COPD in patients with cardiovascular disease
Source: Annual Congress 2009 - Risk factors for COPD
Year: 2009
High prevalence of COPD symtoms in the Tunisian population contrasting with low awareness of the disease
Source: Virtual Congress 2021 – Lung function evaluation and assessment of airway diseases
Year: 2021
Factors associated with disease severity in young adult patients suffering from OSA
Source: Annual Congress 2010 - Screening for sleep-disordered breathing
Year: 2010
Prevalence and impact of depression on COPD
Source: International Congress 2017 – Primary care pulmonary rehabilitation, multimorbidity and organisation of care
Year: 2017
Impact of moderate and severe exacerbations in severe COPD patients
Source: International Congress 2018 – How far are we in terms of predicting mortality and exacerbations in COPD?
Year: 2018
Prevalence and underdiagnosis of COPD by disease severity in middle-aged and elderly
Source: Eur Respir J 2005; 26: Suppl. 49, 470s
Year: 2005
Effects of exacerbation risk on symptoms and clinical characteristics in patients with bronchiectasis
Source: Annual Congress 2012 - Assessment of physical activity, exercise, muscle function and clinical characteristics as outcomes in physiotherapy and rehabilitation
Year: 2012
Predictors of severe exacerbations in patients with moderate and severe asthma
Source: International Congress 2018 – Determinants and monitoring of asthma control
Year: 2018
Comorbidities in COPD patients are not associated to higher disease severity
Source: Annual Congress 2011 - Exercise tests and emerging outcomes: defining the impact of pulmonary rehabilitation
Year: 2011
Home-based evaluation in patients with high risk for moderate to severe OSA
Source: Annual Congress 2012 - CPAP: beneficial effects on different aspects of health
Year: 2012
Obesity in pediatric asthma: prevalence and impact on severity
Source: International Congress 2017 – Insight into childhood asthma and paediatric pulmonology
Year: 2017
Residual symptoms in moderate to severe COVID-19 patients
Source: Virtual Congress 2021 – COVID - 19
Year: 2021
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept